These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30696566)

  • 1. Scotland's National Naloxone Programme.
    Bird SM; McAuley A
    Lancet; 2019 Jan; 393(10169):316-318. PubMed ID: 30696566
    [No Abstract]   [Full Text] [Related]  

  • 2. Scotland's national naloxone program: The prison experience.
    Horsburgh K; McAuley A
    Drug Alcohol Rev; 2018 May; 37(4):454-456. PubMed ID: 28397322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Scotland's national naloxone programme: response to letter to editor.
    Bird SM; McAuley A; Perry S; Hunter C
    Addiction; 2016 Jul; 111(7):1304-6. PubMed ID: 27095522
    [No Abstract]   [Full Text] [Related]  

  • 4. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does take-home naloxone reduce non-fatal overdose?
    Bennett T; Holloway K; Bird SM
    Lancet; 2014 Jan; 383(9912):124-5. PubMed ID: 24411967
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison.
    Bird SM; McAuley A; Perry S; Hunter C
    Addiction; 2016 May; 111(5):883-91. PubMed ID: 26642424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prison-based prescriptions aid Scotland's National Naloxone Programme.
    Bird SM; McAuley A; Munro A; Hutchinson SJ; Taylor A
    Lancet; 2017 Mar; 389(10073):1005-1006. PubMed ID: 28290986
    [No Abstract]   [Full Text] [Related]  

  • 8. Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxone.
    Lobmaier PP; Clausen T
    Addiction; 2016 Apr; 111(4):586-7. PubMed ID: 26995169
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 10. The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.
    Williams S; King T; Papamihali K; Buxton JA
    PLoS One; 2021; 16(5):e0251112. PubMed ID: 33983996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals.
    Eswaran V; Allen KC; Bottari DC; Splawski JA; Bains S; Aks SE; Swoboda HD; Moore PQ; Tran TH; Salisbury-Afshar E; Lank PM; McCarthy DM; Kim HS
    Ann Emerg Med; 2020 Sep; 76(3):318-327. PubMed ID: 32241746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice.
    Matheson C; Pflanz-Sinclair C; Aucott L; Wilson P; Watson R; Malloy S; Dickie E; McAuley A
    BMC Fam Pract; 2014 Jan; 15():12. PubMed ID: 24428947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Quick, Grab the Naloxone": Overdose Preparedness for Ambulatory Clinics.
    Leyde S; Rife T; Kryzhanovskaya I
    Fam Pract Manag; 2021; 28(1):17-22. PubMed ID: 33433179
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.
    McAuley A; Bouttell J; Barnsdale L; Mackay D; Lewsey J; Hunter C; Robinson M
    Addiction; 2017 Feb; 112(2):301-308. PubMed ID: 27614084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a naloxone dispensing program in a grocery store-based community pharmacy.
    Wilkerson DM; Groves BK; Mehta BH
    Am J Health Syst Pharm; 2020 Mar; 77(7):511-514. PubMed ID: 32086505
    [No Abstract]   [Full Text] [Related]  

  • 18. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing opioid overdose in pregnancy with take-home naloxone.
    Blandthorn J; Bowman E; Leung L; Bonomo Y; Dietze P
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):460-462. PubMed ID: 29271100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency medicine services providers' attitudes toward naloxone distribution and training programs.
    Montoy JCC; Mercer MP; Silverman EC; Raven MC; LeSaint KT
    Am J Emerg Med; 2022 Jan; 51():76-78. PubMed ID: 34688204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.